Figure 4.
MSC-derived exosomal miRNAs mitigate apoptosis, contributing to the potential treatment of cardiac fibrosis and heart failure. MSC-derived exosome contain anti-apoptotic miRNAs that by targeting pro-apoptotic mRNAs suppress apoptosis, reducing cardiomyocyte apoptosis. These findings highlights stem cell–derived exosome-mediated therapeutic potential in mitigating cardiac fibrosis and heart failure.
